Neumora Therapeutics (NasdaqGS:NMRA) 2025 R&D Day October 27, 2025 08:00 AM ET Company ParticipantsHelen Rubinstein - VP of Investor Relations and CommunicationsGraig Suvannavejh - Managing DirectorBill Aurora - Chief Operating and Development OfficerNick Brandon - Chief Scientific OfficerDouglas Tsao - Managing DirectorPaul Berns - Co-founder, CEO, and ChairmanAnton Porsteinsson - Director of Alzheimers Disease Care Research and Education ProgramJosh Pinto - PresidentBrian Abrahams - Managing Director and ...